San Diego, CA, United States of America

Julie Laterreur

This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julie Laterreur. Retrieved from https://idiyas.com/inventor/julie-laterreur

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 17.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Julie Laterreur

Introduction

Julie Laterreur is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. With a total of 2 patents to her name, her work is recognized for its potential impact on patient care.

Latest Patents

Julie Laterreur's latest patents focus on modulators of the cystic fibrosis transmembrane conductance regulator (CFTR). These disclosures provide valuable insights into pharmaceutical compositions that contain at least one modulator, methods of treatment for cystic fibrosis, and processes for creating these modulators. Her innovative approach aims to enhance the quality of life for individuals affected by this condition.

Career Highlights

Currently, Julie Laterreur is associated with Vertex Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving therapeutic options for patients suffering from cystic fibrosis.

Collaborations

Throughout her career, Julie has collaborated with notable colleagues, including Jeremy J Clemens and Brett C Bookser. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Julie Laterreur's contributions to the field of pharmaceutical sciences exemplify the impact of dedicated inventors in addressing complex health challenges. Her work in developing modulators for cystic fibrosis treatment showcases her commitment to improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…